Drug
Drug Icp 192
Drug Icp 192: highest development phase Phase 1/2, developed by InnoCare Pharma. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- InnoCare Pharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| Drug ICP-192 NCT04565275 | Phase 1/2 | Advanced Solid Tumors |
Latest
No recent events.
Follow Drug Icp 192 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.